腺病毒载体的研究进展
范凌云,谢庆军
摘要(Abstract)：
目的由于腺病毒载体转导目的基因具有高效率、低致病性、高滴度以及在体内不整合入宿主细胞染色体等优点,已被认为是最有效的转基因载体之一,并广泛应用于人类基因治疗。但是腺病毒载体还存在一些不足,如具有一定的免疫原性和毒性等,尚有待进一步解决。随着腺病毒载体研究的进展,新的载体系统必将在基因治疗中发挥更重要的作用。本文对腺病毒载体的研究进展作一综述。
关键词(KeyWords)：
腺病毒;载体;基因治疗
基金项目(Foundation):
作者(Author):
范凌云,谢庆军
DOI: 10.13200/j.cjb.2008.02.78.fanly.004
参考文献(References)：
- [1]Nadeau I,Kamen A.Production of adenovirus vector for gene therapy.Biotechnol Adv,2003,20(7~8):475-489.
- [2]Wilmott RW,Amin RS,Perez CR,et al.Safety of adenovirus-mediatedtransfer of the human cystic fibrosis transmembrane conductance regulatorcDNA to the lungs of nonhuman primates.Hum Gene Ther,1996,7(3):301-318.
- [3]Hehir KM,Armentano D,Cardoza LM,et al.Molecular characterization ofreplication-competent variants of adenovirus vectors and genome modifica-tions to prevent their occurrence.J Virol,1996,70(12):8459-8467.
- [4]Engelhardt JF,Ye X,Doranz B,et al.Ablation of E2A in recombinantadenoviruses improves transgene persistence and decreases inflammatoryresponse in mouse liver.Proc Natl Acad Sci USA.1994,91(13):6196-6200.
- [5]Parks RJ,Graham FL.A helper-dependent system for adenovirus vectorproduction helps define a lower limit for efficient DNA packaging.J Vi-rol,1997,71(4):3293-3298.
- [6]Sato M,Suzuki S,Kubo S,et al.Replication and packaging of helper de-pendent-adenoviral vector.Gene Ther,2002,9(7):472-476.
- [7]Ng P,Beauchamp C,Evelegh C,et al.Development of a FLP/frt systermfor generating helper-dependent adenoviral vectors.Mol Ther,2001,3(5Pt 1):809-815.
- [8]He TC,Zhou S,Da Costa LT,et al.A simplified system for generating re-combinant adenoviruses.Proc Natl Acad Sci USA,1998,95(5):2509-2514.
- [9]Ng P,Parks RJ,Cummings DT,et al.An enhanced system for construc-tion of adenoviral vectors by the two-plasmid rescue method.Hum GeneTher,2000,11(5):693-699.
- [10]Massie B,Mosser DD,Koutroumanis M,et al.New adenovirus vectorsfor protein production and gene transfer.Cytotechnology,1998,28:53-64.
- [11]Matthews D A,Cummings D,Evelegh C,et al.Development of a modi-fied 293 cell lineexpressing the lac repressor an its use in the rescue ofrecombinant adenoviruses expressing high levels of rabies virus glyco-protein.J Gen Virol.1999,80(Pt 2):345-353.
- [12]谢庆军,范凌云,李季凤,等.Kozak序列引导的人p53基因重组智能腺病毒载体的构建与表达.中国生物制品学杂志,2008,21(2):107~110,118.
- [13]McNeish IA,Bell SJ,Lemoine NR.Gene therapy progress andprospects:cancer gene therapy using tumour suppressor genes.GeneTher,2004,11(6):497-503.
- [14]Kasuya H,Takeda S,Nomoto S,et al.The potential of oncolytic virustherapy for pancreatic cancer.Cancer Gene Ther,2005,12(9):725-736.
- [15]袁中玉,张力,李苏,等.E1B缺失腺病毒瘤内注射治疗恶性肿瘤的安全性研究.癌症,2003,22(3):310~313.
- [16]徐瑞华,袁中玉,管忠震,等.瘤内注射E1B缺失腺病毒(H101)与化疗联合治疗恶性肿瘤的Ⅱ期临床试验.癌症,2003,22(12):1307~1310.
- [17]夏忠军,常建华,张力,等.基因工程腺病毒(H101)瘤内注射联合化疗治疗头颈部及食管鳞癌的Ⅲ期临床试验.癌症,2004,23(12):1666~1670.
- [18]Ohashi M,Kanai F,Tateishi K,et al.Target gene therapy for alpha-feto-protein-producing hepatocellular carcinoma by E1B55k-attenuated aden-ovirus.Biochem Biophys Res Commun,2001,282(2):529-535.
- [19]吴文溪,沈历宗,刘新垣,等.含胞嘧啶脱氨酶基因的靶向腺病毒载体的构建及应用.实用癌症杂志,2002,17(3):233~237.
- [20]Kawashima T,Kagawa S,Kobayashi N,et al.Telomerase-specific repli-cation-selective virotherapy for human cancer.Clin Cancer Res,2004,10(1 Pt 1):285-292.
- [21]Shirakawa T,Hamada K,Zhang Z,et al.A cox-2 promoter-based repli-cation-selective adenoviral vector to target the cox-2-expressing humanbladder cancer cells.Clin Cancer Res,2004,10(13):4342-4348.
- [22]Kesmodel S,Prabakaran I,Canter R,et al.Virus-mediated Oncolysis ofthyroid cancer by a replication-selective adenovirus driven by a thy-roglobulin promoter-enhancer region.J Clin Endocrinol Metab,2005,90(6):3440-3448.
- [23]Chen Y,DeWeese T,Dilley J,et al.CV706,a prostate cancer-specificadenovirus variant,in combination with radiotherapy produces synergis-tic antitumor efficacy without increasing toxicity.Cancer Res,2001,61(14):5453-5460.
- [24]Katabi MM,Chan HL,Karp SE,et al.Hexokinase type II:a novel tu-mor-specific promoter for gene-targeted therapy differentially expressedand regulated in human cancer cells.Hum Gene Ther,1999,10(2):155-164.
- [25]Manome Y,Kunieda T,Wen PY,et al.Transgene expression in malig-nant glioma using a replication-defective adenoviral vector containingthe Egr-1 promoter:activation by ionizing radiation or uptake of radioac-tive iododeoxyuridine.Hum Gene Ther,1998,9(10):1409-1417.
- [26]Dmitriev I,Krasnykh V,Miller CR,et al.An adenovirus vector with ge-netically modified fibers demonstrates expanded tropism via utilization ofa coxsackievirus and adenovirus receptor-independent cell entry mecha-nism.J Virol 1998,72(12):9706-9713.
- [27]Hemminki A,Zinn KR,Liu B,et al.In vivo molecular chemotherapyand noninvasive imaging with an infectivity-enhanced adenovirus.J NatlCancer Inst,2002,94(10):741-749.
- [28]Koizumi N,Mizuguchi H,Utoguchi N,et al.Generation of fiber-modifiedadenovirus vectors containing heterologous peptides in both the HI loopand C terminus of the fiber knob.J Gene Med,2003,5(4):267-276.
- [29]叶迅,陆琴,赵毅,等.嵌合型E1B 55-kDa蛋白缺陷型腺病毒载体治疗肿瘤的评价.生物化学与生物物理进展,2005,32(12):1156~1164.
- [30]Shayakhmetov DM,Li ZY,Ni S,et al.Analysis of adenovirus sequestra-tion in the liver,transduction of hepatic cells,and innate toxicity afterinjection of fiber-modified vectors.J Virol,2004,78(10):5368-5381.
- [31]Rancourt C,Rogers BE,Sosnowski BA,et al.Basic fibroblast growthfactor enhancement of adenovirus-mediated delivery of the herpes sim-plex virus thymidine kinase gene results in augmented therapeutic bene-fit in a murine model of ovarian cancer.Clin Cancer Res,1998,4(10):2455-2461.
- [32]Gu DL,Gonzalez AM,Printz MA,et al.Fibroblast growth factor 2 retar-geted adenovirus has redirected cellular tropism:evidence for reducedtoxicity and enhanced antitumor activity in mice.Cancer Res,1999,59(11):2608-2614.
- [33]Krasnykh V,Dmitriev I,Navarro JG,et al.Advanced generation aden-oviralvectors possess augmented gene transfer efficiency based upon cox-sackie adenovirus receptor-independent cellular entry capacity.CancerRes,2000,60(24):6784-6787.